Followers | 29 |
Posts | 5328 |
Boards Moderated | 0 |
Alias Born | 11/29/2016 |
Wednesday, February 14, 2018 10:25:19 AM
Tauriga Sciences, Inc. (OTC PINK Current Tier: TAUG) (“Tauriga” or the “Company”), engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities/equity investments, today announced that it has fully repaid and retired a $27,500 Face Value 8.00% convertible debenture (the “Note”) held by Adar Bays, LLC (“Adar Bays”); this Note was funded by Adar Bays on October 3, 2017 and was issued as a back end convertible note pursuant to an original debenture dated February 8, 2017, carrying a 10% original issue discount in the amount of $2,500 bearing an interest rate of 8% with a default rate of 24%. As this above-referenced Note was repaid in full (and in a timely manner) for a one-time cash payment of $39,312.78, there will be no conversions that occur in conjunction with this Note. Accordingly, this debt has now been removed from the Company’s balance sheet.
For more information on this Note, please review Tauriga’s recently filed Quarterly Report (see below link) on Form 10-Q for the 3rd Fiscal Quarter of 2018 (Period Ending: December 31, 2017):
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM